Author:
Changzeng Wei,Wanshun Liu,Baoqin Han,Yixiang Duan
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Lau E M O. Epidemiology of Osteoporosis [J].Best Practice Res Clin Rheumatol, 2001,15:335–344.
2. Harris S T, Watts N B, Genant H K,et al. Effects of Rise-dronate on Vertebral and on Vertebral Fractures in Women with Postmenopausal Osteoporosis: a Randomized Controlled Trial [J].JAMA, 1999,282:1344–1352.
3. Black D M, Cummings S R, Karpf D B,et al. Randommised Trial of Effect of Alendronate on Risk of Fracture in Women with Existing Vertebral Fractures [J].Lancet, 1996,348:1435–1441.
4. Tam C H, Heersche J N, Murray T M. Parathyroid Hormone Stimulates the Bone Apposition Rate Independently of its Resorptive Action: Differential Effects of Intermittent and Continuous Administration [J].Endocrinology, 1982,110: 506–512.
5. Cosman F, Nieves J, Woelfert L,et al. Parathyroid Hormone Added to Established Hormone Theraphy: Effects on Vertebral Fracture and Maintenance of Bone Mass after Parathyroid Hormone Withdrawal [J].J Bone Miner Res, 2001,16:925–931.